Article Information
History
- June 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kazuki M Matsuda, MD, PhD1,*,
- Yoshiaki Kawase, PhD2,*,
- Kazuhiro Iwadoh, MD, PhD1,
- Makoto Kurano, MD, PhD3,
- Yutaka Yatomi, MD, PhD4,
- Koh Okamoto, MD, MS, PhD5,
- Kyoji Moriya, MD, PhD5,6,
- Hirohito Kotani, MD, PhD1,
- Teruyoshi Hisamoto, MD, PhD1,
- Ai Kuzumi, MD, PhD1,
- Takemichi Fukasawa, MD, PhD1,7,
- Asako Yoshizaki-Ogawa, MD, PhD1,
- Masanori Kono, MD, PhD8,
- Tomohisa Okamura, MD, PhD8,
- Hirofumi Shoda, MD, PhD8,
- Keishi Fujio, MD, PhD8,
- Kei Yamaguchi, PhD9,
- Taishi Okumura9,
- Chihiro Ono9,
- Yuki Kobayashi, PhD9,
- Ayaka Sato9,
- Ayako Miya, PhD9,
- Naoki Goshima, PhD9,
- Rikako Uchino10,
- Yumi Murakami, PhD10,
- Hiroshi Matsunaka, PhD10,
- Hiroshi Imai, PhD2,
- Shinichi Sato, MD, PhD1,
- Rudy Raymond, PhD2 and
- Ayumi Yoshizaki, MD, PhD1,7,#
- 1Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 2Department of Computer Science, The University of Tokyo Graduate School of Information Science and Technology, Tokyo, Japan
- 3Department of Clinical Laboratory Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 4Graduate School, International University of Health and Welfare, Tokyo, Japan
- 5Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan
- 6Division of Infection Prevention and Control, Postgraduate School of Healthcare, Tokyo Healthcare University, Tokyo, Japan
- 7Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 8Department of Allergy and Rheumatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 9ProteoBridge Corporation, Tokyo, Japan
- 10NOV Academic Research, TOKIWA Pharmaceutical Co., Ltd., Tokyo, Japan
- ↵#Corresponding authors
Ayumi Yoshizaki, MD, PhD Department of Dermatology and Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 1138655 Phone: +81-3-3815-5411 E-mail: ayuyoshi{at}me.com
↵* Equally contributed.
Posted June 08, 2024.
Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape
